These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 28923989)

  • 1. Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes.
    Fanaroff AC; Roe MT; Clare RM; Lokhnygina Y; Navar AM; Giugliano RP; Wiviott SD; Tershakovec AM; Braunwald E; Blazing MA
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28923989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
    Murphy SA; Cannon CP; Blazing MA; Giugliano RP; White JA; Lokhnygina Y; Reist C; Im K; Bohula EA; Isaza D; Lopez-Sendon J; Dellborg M; Kher U; Tershakovec AM; Braunwald E
    J Am Coll Cardiol; 2016 Feb; 67(4):353-361. PubMed ID: 26821621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (studie IMPROVE-IT)].
    Špinar J; Špinarová L; Vítovec J
    Vnitr Lek; 2014 Dec; 60(12):1095-101. PubMed ID: 25692840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.
    Lopes RD; Leonardi S; Neely B; Neely ML; Ohman EM; Ardissino D; Hamm CW; Goodman SG; Bhatt DL; White HD; Prabhakaran D; Martinez F; Nicolau JC; Winters KJ; Fox KA; Armstrong PW; Roe MT
    J Am Coll Cardiol; 2016 Mar; 67(11):1289-97. PubMed ID: 26988949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT).
    Sharma A; Sun JL; Lokhnygina Y; Roe MT; Ahmad T; Desai NR; Blazing MA
    Am J Cardiol; 2019 Apr; 123(8):1193-1201. PubMed ID: 30739657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognosis following acute coronary syndromes: a prospective observational study of an unselected group treated in the 24/7 cardiac catheterisation laboratory at a university hospital.
    Grabowski M; Filipiak KJ; Opolski G; Główczyńska R; Gawałko M; Balsam P; Cacko A; Huczek Z; Karpiński G; Kowalik R; Majstrak F; Kochman J
    Kardiol Pol; 2018; 76(4):755-763. PubMed ID: 29313559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
    Blazing MA; Giugliano RP; Cannon CP; Musliner TA; Tershakovec AM; White JA; Reist C; McCagg A; Braunwald E; Califf RM
    Am Heart J; 2014 Aug; 168(2):205-12.e1. PubMed ID: 25066560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and 30-day outcome of women with acute coronary syndrome as a first manifestation of ischemic heart disease: A single-center observational study.
    Nanjappa V; Aniyathodiyil G; Keshava R
    Indian Heart J; 2016; 68(2):164-8. PubMed ID: 27133325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
    Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
    Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome.
    Hess PL; Wojdyla DM; Al-Khatib SM; Lokhnygina Y; Wallentin L; Armstrong PW; Roe MT; Ohman EM; Harrington RA; Alexander JH; White HD; Van de Werf F; Piccini JP; Held C; Aylward PE; Moliterno DJ; Mahaffey KW; Tricoci P
    JAMA Cardiol; 2016 Apr; 1(1):73-9. PubMed ID: 27437658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Kato ET; Cannon CP; Blazing MA; Bohula E; Guneri S; White JA; Murphy SA; Park JG; Braunwald E; Giugliano RP
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
    Cannon CP; Giugliano RP; Blazing MA; Harrington RA; Peterson JL; Sisk CM; Strony J; Musliner TA; McCabe CH; Veltri E; Braunwald E; Califf RM;
    Am Heart J; 2008 Nov; 156(5):826-32. PubMed ID: 19061694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
    Lancellotti P; Pierard LA; Scheen AJ
    Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes?
    Biswas S; Andrianopoulos N; Papapostolou S; Noaman S; Duffy SJ; Lefkovits J; Brennan A; Walton A; Shaw JA; Ajani A; Clark DJ; Freeman M; Hiew C; Oqueli E; Reid CM; Stub D; Chan W
    Eur Heart J Qual Care Clin Outcomes; 2018 Oct; 4(4):318-327. PubMed ID: 30124800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka.
    Ralapanawa U; Kumarasiri PVR; Jayawickreme KP; Kumarihamy P; Wijeratne Y; Ekanayake M; Dissanayake C
    BMC Cardiovasc Disord; 2019 Oct; 19(1):229. PubMed ID: 31638908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Morici N; Savonitto S; Ferri LA; Grosseto D; Bossi I; Sganzerla P; Tortorella G; Cacucci M; Ferrario M; Crimi G; Murena E; Tondi S; Toso A; Gandolfo N; Ravera A; Corrada E; Mariani M; Di Ascenzo L; Petronio AS; Cavallini C; Vitrella G; Antonicelli R; Piscione F; Rogacka R; Antolini L; Alicandro G; La Vecchia C; Piatti L; De Servi S;
    Am J Med; 2019 Feb; 132(2):209-216. PubMed ID: 30447205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.
    Almalki ZS; Guo JJ; Alahmari A; Alotaibi N; Thaibah H
    Heart Lung Circ; 2018 Jun; 27(6):656-665. PubMed ID: 28716519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of antithrombotic management patterns in acute coronary syndrome patients.
    Ertaş FS; Tokgozoglu L;
    Turk Kardiyol Dern Ars; 2018 Apr; 46(3):175-183. PubMed ID: 29664423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study.
    Sawhney JPS; Mullasari A; Kahali D; Mehta V; Nair T; Kaul U; Hirematth MS
    Indian Heart J; 2019; 71(1):25-31. PubMed ID: 31000179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and long term outcomes of patients with acute coronary syndromes due to culprit left main coronary artery disease treated with percutaneous coronary intervention.
    Gharacholou SM; Ijioma NN; Lennon RJ; Rihal CS; Bell MR; Brenes-Salazar JA; Sandhu GS; Gulati R; Pellikka PA; Pollak PM; Lane GE; Pillai DP; Munoz FD; Motiei A; Singh M
    Am Heart J; 2018 May; 199():156-162. PubMed ID: 29754655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.